- Report
- February 2026
- 372 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 468 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 374 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 281 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 370 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 375 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 478 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 207 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 371 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 271 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 374 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 380 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 473 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 373 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 186 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 385 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 177 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 274 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 373 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- February 2026
- 383 Pages
Global
From €5103EUR$5,850USD£4,447GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more